Ritodrine

Chemical formula: C₁₇H₂₁NO₃  Molecular mass: 287.359 g/mol  PubChem compound: 33572

Therapeutic indications

Ritodrine is indicated for:

Indication

Population group: women, only adults (18 - 65 years old)

at least one of
Premature separation of placenta [abruptio placentae]
Preterm labour
Other preterm infants

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Ritodrine is contraindicated in the following cases:

Contraindication

at least one of
Hypertension
Mild to moderate pre-eclampsia
Severe pre-eclampsia
Pre-eclampsia, unspecified
Eclampsia
Continuing pregnancy after intrauterine death of one fetus or more
Fetus and newborn affected by chorioamnionitis
Thyrotoxicosis [hyperthyroidism]
Hypertension
Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium
Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium
Beta blocking agents
Beta blocking agents

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈